In the last trading session, 4.54 million shares of the Gilead Sciences Inc. (NASDAQ:GILD) were traded, and its beta was 0.41. Most recently the company’s share price was $78.58, and it changed around -$0.04 or -0.05% from the last close, which brings the market valuation of the company to $97.23B. GILD currently trades at a discount to its 52-week high of $89.74, offering almost -14.2% off that amount. The share price’s 52-week low was $57.17, which indicates that the current value has risen by an impressive 27.25% since then. We note from Gilead Sciences Inc.’s average daily trading volume that its 10-day average is 4.71 million shares, with the 3-month average coming to 5.35 million.
Gilead Sciences Inc. (NASDAQ:GILD) trade information
Instantly GILD has showed a red trend with a performance of -0.05% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 79.85 on Tuesday, 05/23/23 increased the stock’s daily price by 1.59%. The company’s shares are currently down -8.47% year-to-date, but still up 0.33% over the last five days. On the other hand, Gilead Sciences Inc. (NASDAQ:GILD) is -9.37% up in the 30-day period. We can see from the shorts that 19.28 million shares have been sold at a short interest cover period of 3.65 day(s).
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
The consensus price target as assigned by Wall Street analysts is $91.50, which translates to bulls needing to increase their stock price by 14.12% from its current value. Analyst projections state that GILD is forecast to be at a low of $77.00 and a high of $115.00. In order for the stock price to hit the forecast high, the stock would need to plunge -46.35% from its current level, while the stock would need to crash 2.01% from its current level to reach the projected low.
Gilead Sciences Inc. (GILD) estimates and forecasts
Gilead Sciences Inc. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -6.03 percent over the past six months and at a -7.16% annual growth rate that is well below the industry average of 11.20%. Moreover, analysts have decided to roll up on their fiscal year 2023 revenue estimates. The rating firms predict that it will gain 8.20% in revenue this quarter, and will report a decrease of -1.10% in the next quarter. The year-over-year growth rate is expected to be -2.10%, down from the previous year.
Consensus estimates provided by 20 financial analysts predict the company will bring in an average of $6.48 billion in revenue for the current quarter. 19 analysts expect Gilead Sciences Inc. to make $6.81 billion in revenue for the quarter ending Sep 2023. The company’s sales for the same quarters a year ago were $6.26 billion and $6.12 billion respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 3.50%. Forecasts for the next quarter put sales growth at 11.30%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -13.90%. Gilead Sciences Inc. earnings are expected to increase by -26.20% in 2023, but the outlook is positive 2.25% per year for the next five years.
Gilead Sciences Inc.’s next quarterly earnings report is expected to be released around July 31 and August 04. The annual dividend yield of the stock is 3.82 percent and its annual dividend per share was 3.00. It is important to note, however, that the 3.82% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.
Gilead Sciences Inc. (NASDAQ:GILD)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.10% of Gilead Sciences Inc. shares, and 85.97% of them are in the hands of institutional investors. The stock currently has a share float of 86.06%. Gilead Sciences Inc. stock is held by 2,365 institutions, with Blackrock Inc. being the largest institutional investor. By Mar 30, 2023, it held 10.15% of the shares, which is about 126.56 million shares worth $10.5 billion.
Vanguard Group, Inc. (The), with 9.06% or 112.97 million shares worth $9.37 billion as of Mar 30, 2023, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Income Fund of America Inc were the top two Mutual Funds as of Dec 30, 2022. The former held 38.12 million shares worth $3.27 billion, making up 3.05% of all outstanding shares. On the other hand, Income Fund of America Inc held roughly 33.74 million shares worth around $2.8 billion, which represents about 2.70% of the total shares outstanding.